By |

Profile

Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred, Ulesfia, Karbinal ER, AcipHex Sprinkle and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber.

Contact Information

Website: www.cerecor.com
Email: john.woolford@westwicke.com
Main Phone: +1 410 522-8707
Address: 540 Gaither Road
Address 2: Suite 400
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NSC
CEO: Peter S. Greenleaf
Employees: 64
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Cerecor Inc is a biopharmaceutical company with commercial operations and research and development capabilities. The Company is building a robust pipeline of innovative therapies in neurology, pediatric healthcare, and orphan rare diseases. The Company is also developing three other neurological clinical and preclinical stage compounds. The Company's pediatric orphan rare disease pipeline is led by CERC-801, CERC-802 and CERC-803. The Company also markets prescription drugs that treat a range of pediatric diseases, disorders and conditions. Cerecor's prescription drugs include Millipred, Ulesfia, Karbinal ER, AcipHex Sprinkle and Cefaclor for Oral Suspension. The Company has marketed medical device, Flexichamber.

Contact Information

Website: www.cerecor.com
Email: john.woolford@westwicke.com
Main Phone: +1 410 522-8707
Address: 540 Gaither Road
Address 2: Suite 400
State: MD
City / Town: Rockville
Country: USA
Postal Code: 20850

Issuer Information

Exchange: NSC
CEO: Peter S. Greenleaf
Employees: 64
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 5.53 $ 0.02 (0.36%)
Last Price 5.53 Change $ 0.02 Change % 0.36 Tick N/A
Bid 5.51 Bid Size 100.00 Ask 5.56 Ask Size 300.00
Open 5.50 High 5.63 Low 5.00 Prev Close 5.51
Last Trade Volume 34,948 52 Wk Hi 7.65 52 Wk Low 2.71
Market Cap 235.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 42,653,659.00 EPS (TTM) -1.17 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 2 3
Number of Buys 2 3
Number of Sells 0 0
Net Activity 412500 412785
Last 10 Buys Shares
Peter Lichtlen 1,000
Robert C. Moscato 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 5.5 5.5 5.5 5.5
Low Target Price Estimate 5.5 5.5 5.5 5.5
Mean Target Price Estimate 5.5 5.5 5.5 5.5
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 05/17/18 05/17/18 05/17/18 05/17/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 3